Landmark analysis (after cycle 18) of PFS. PFS differences between positive and negative patients by (A) MS, (B) NGS at the 10^–5 threshold, and (C) MFC. Not all patients included in this analysis had the BM MRD testing results available, hence the lower numbers of cases presented in panels B and C.